TFF3 and cancer: In the future, machine learning might help to homogenise pathology scoring and reduce pathologist assessment time, as we have previously shown for TFF3. 26We have also shown that a relatively simple measurement of the genomic alterations in a biopsy can predict future risk of cancer up to 8 years in advance.27